Brokerage Reports: Cipla Faces Supply Woes, Infosys Bullish, HDFC AMC Strong

• Cipla faces significant earnings impact due to Lanreotide supply disruption, with brokerages like Morgan Stanley and Nuvama cutting estimates, while Nomura believes risk is priced in.
• Infosys receives bullish ratings from HSBC, CLSA, Jefferies, and Nuvama, citing strong deal wins, improving demand in Banking/Energy, and growth in AI-based work.
• Jio Financial shows stable growth with a 29% QoQ AUM increase and a growing Payments Bank customer base, with Jefferies seeing no financial strength concerns.
• L&T Technology Services faces caution from HSBC and Nomura due to weak Q3, business recalibration, and concerns over future growth despite a strong deal pipeline.
• HDFC AMC is bullish across four brokerages (Nomura, HSBC, CLSA, Nuvama) due to strong Equity and Passive AUM growth and excellent Q3 performance.

Why It Matters: Brokerages show mixed views: caution on Cipla and L&T Tech, but strong confidence in Infosys, Jio Financial, and HDFC AMC.